v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Cash flows from operating activities:    
Net income $ 425,677 $ 254,603
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation expense 178,953 201,569
Amortization of deferred contract acquisition costs 51,515 69,557
Depreciation and amortization 32,781 35,316
Deferred income taxes 23,294 (24,690)
(Gains) losses on strategic investments, net (152,297) 13,619
Provision for accounts receivable allowances 3,026 5,855
Unrealized foreign exchange losses (gains) 664 (7,626)
Non-cash operating lease cost 5,884 6,108
Amortization of discount/premium on marketable securities (1,293) (12,845)
Other 7,350 4,142
Changes in operating assets and liabilities:    
Accounts receivable 24,690 12,485
Prepaid expenses and other assets 3,116 (12,293)
Deferred contract acquisition costs (86,742) (48,148)
Accounts payable 10,327 7,252
Accrued expenses and other liabilities (67,748) (80,383)
Deferred revenue 69,605 72,141
Operating lease liabilities, net (7,192) (7,401)
Net cash provided by operating activities 521,610 489,261
Cash flows from investing activities:    
Purchases of marketable securities (1,172,217) (1,135,024)
Maturities of marketable securities 858,125 1,033,279
Sales of marketable securities 0 2,525
Purchases of property and equipment (21,113) (25,910)
Purchases of strategic investments (145,695) 0
Proceeds from strategic investments 184 0
Net cash used in investing activities (480,716) (125,130)
Cash flows from financing activities:    
Proceeds from exercise of stock options 504 954
Proceeds from employee equity transactions to be remitted to employees and tax authorities, net 29,237 8,690
Cash paid for repurchases of common stock (361,683) (418,021)
Taxes paid related to net share settlement of equity awards (62,168) (82,153)
Net cash used in financing activities (394,110) (490,530)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 314 11,854
Net decrease in cash, cash equivalents, and restricted cash (352,902) (114,545)
Cash, cash equivalents, and restricted cash – beginning of period 1,283,781 1,361,417
Cash, cash equivalents, and restricted cash – end of period 930,879 1,246,872
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:    
Cash and cash equivalents 890,938 1,228,847
Restricted cash, current included in prepaid expenses and other current assets 39,941 18,025
Total cash, cash equivalents, and restricted cash $ 930,879 $ 1,246,872